N-Acetyl Cysteine para Depression-Related Cognitive Dysfunction

Research suggests NAC's glutamate modulation and glutathione restoration may help address cognitive aspects of depression. Evidence is emerging from several clinical studies exploring NAC as an adjunctive treatment.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dn\u002Dacetyl\u002Dcysteine\u0026condition\u003Ddepression\u002Dcognitive'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

Conclusión

Key Study Findings

Review

Akathisia and Restless Legs Syndrome: Solving the Dopaminergic Paradox.

Dose: None vs: None Outcome: None Efecto: None None

Población: restless legs syndrome

Review

Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?

Dose: None vs: None Outcome: None Efecto: None None

Población: None

Other n=24 2 weeks

N-acetyl-l-cysteine attenuates oxidative damage and neurodegeneration in rat brain during aging.

Dose: NAC 100 mg/kg body weight orally daily for 14 days vs: Placebo Efecto: significant augmentation of antioxidants and reduction of prooxidants in old rats; downregulation of None

Review

Restless legs syndrome.

Dose: None vs: None Outcome: quality of life Efecto: None None

Población: cardiovascular patients

In Vitro

Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro.

Dose: Valerian extract and valerenic acid vs: LSD binding Outcome: 5-HT5a receptor binding affinity Efecto: PE extract IC50 15.7 ng/ml (high affinity) None

Población: None

Key Statistics

Estudios

400

Participantes

↑

Positive

Calificación

Referenced Papers

Akathisia and Restless Legs Syndrome: Solving the Dopaminergic Paradox. Review

Sleep medicine clinics 2021 14 citas

Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia? Review

Neuroscience and biobehavioral … 2019 45 citas

N-acetyl-l-cysteine attenuates oxidative damage and neurodegeneration in rat brain during aging. Other

Canadian journal of … 2018 37 citas

Restless legs syndrome. Review

Handbook of clinical … 2011 8 citas

Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro. Other

Brain research. Molecular … 2005 160 citas

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosificaciones de uso común

general:: 600-1,800 mg/day
neuroprotection:: 1,200-2,400 mg/day

Límite superior: Not established as supplement; 6,000+ mg/day used clinically (IV)

Dosificaciones estudiadas en la investigación

Dosificación	Duración	Efecto	N
None	--	Mixed	--
None	--	Positive	--
NAC 100 mg/kg body weight orally daily for 14 days	2 weeks	Positive	24
None	--	Mixed	--
Valerian extract and valerenic acid	--	Positive	--

Mejor momento para tomar: On empty stomach; split into 2-3 doses; supplement zinc if using long-term

Safety & Side Effects

Efectos secundarios reportados

⚠ Nausea and vomiting
⚠ Diarrhea
⚠ Unpleasant sulfur taste/smell
⚠ Rare: bronchospasm (inhaled form)
⚠ Long-term use may deplete zinc stores

Interacciones conocidas

● Nitroglycerin (may enhance hypotensive effects)
● Activated charcoal (reduces NAC absorption)
● Anticoagulants (theoretical interaction)

Ingesta máxima tolerable: Not established as supplement; 6,000+ mg/day used clinically (IV)

Consulte siempre a su profesional de salud antes de comenzar cualquier suplemento.Siempre consulte a su profesional de salud antes de comenzar cualquier suplemento.

Frequently Asked Questions

Does N-Acetyl Cysteine help with Depression-Related Cognitive Dysfunction?

Based on 6 studies with 400 participants, there is limited but promising evidence that N-Acetyl Cysteine may support Depression-Related Cognitive Dysfunction management. Our evidence grade is C (Some Evidence).

How much N-Acetyl Cysteine should I take for Depression-Related Cognitive Dysfunction?

Studies have used various dosages. A commonly studied range is 600-1,800 mg/day. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of N-Acetyl Cysteine?

Reported side effects may include Nausea and vomiting, Diarrhea, Unpleasant sulfur taste/smell, Rare: bronchospasm (inhaled form). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for N-Acetyl Cysteine and Depression-Related Cognitive Dysfunction?

We rate the evidence as Grade C (Some Evidence). This rating is based on 6 peer-reviewed studies with 400 total participants. The overall direction of effect is positive.

Related Evidence

Otros ingredientes para Depression-Related Cognitive Dysfunction

Omega-3 Fatty Acids (DHA/EPA) B Vitamin D C

N-Acetyl Cysteine para otras condiciones

Oxidative Stress & Neuroinflammation B Post-Concussion Cognitive Symptoms B

Veredicto rápido

Evidence Strength52%

Moderate confidence

Desglose de estudios

RCT (0)Meta (0)Other (6)

Comparar alternativas

Vea cómo se comparan otros ingredientes para esta condición.

Ver todos los ingredientes para Depression-Related Cognitive Dysfunction

Más información

Aviso legal FDA: Estas declaraciones no han sido evaluadas por la Food and Drug Administration. Los productos y la información en este sitio web no están destinados a diagnosticar, tratar, curar ni prevenir ninguna enfermedad. Las calificaciones de evidencia presentadas se basan en nuestro análisis de investigación publicada revisada por pares y no constituyen consejo médico. Siempre consulte a su profesional de salud antes de comenzar cualquier régimen de suplementos.